Gabriel Capellá, M.D., Ph.D.

Gabriel Capellá is the General Director of the Bellvitge Biomedical Research Institute (IDIBELL) a research center in biomedicine sponsored by the Bellvitge University Hospital and the Viladecans Hospital (both from the Catalan Health Institute), the Catalan Institute of Oncology (ICO), the University of Barcelona, and L’Hospitalet de Llobregat city council. He is also the Director of the Hereditary Cancer Program at ICO. He formerly served as Vice-Director for Research and Innovation, Health Department, Catalan Government and has been a visiting professor at the University of Michigan. His research has primarily focused on the genetic basis of gastrointestinal cancer, developing novel technologies for the clinical management of patient at risk of developing GI Cancers.